Search

everythinglearnresearchcommunity

for

Search:↓

Vitiligo is now seen as a systemic disease with promising new treatments and may offer protection against some diseases.

Blocking certain pathways with kinase inhibitors may help treat cutaneous lupus erythematosus.

Understanding how acne develops in different diseases could lead to new treatments.

The combination of calcipotriol and PRP is the most effective treatment for alopecia areata.

Finasteride reverses early hair loss and promotes growth.

The conclusion is that primary scarring alopecia is a complex condition that requires early and accurate diagnosis for effective treatment.

Intralesional corticosteroids work best for mild alopecia areata, and DPCP works best for moderate to severe cases.

Oral dutasteride works better for hair loss, but has more sexual side effects; intralesional dutasteride is a possible alternative.

A woman with a rare scalp lymphoma had unusual hair loss after treatment.

People with alopecia areata have higher levels of osteopontin, which might be important in the disease's development, but this doesn't relate to how severe the disease is.

miR-200c-3p could help diagnose and treat alopecia areata.

AFM can help diagnose lichen planopilaris by identifying specific hair structure changes.

Current research on seborrheic dermatitis highlights key focus areas and suggests future study directions.

Stress may trigger hair loss by affecting immune protection in hair follicles.

Topical rosuvastatin and melatonin creams significantly reduce psoriasis severity and are safe.

The research suggests that immune cells and a specific type of cell death called ferroptosis are involved in Frontal fibrosis alopecia.

Claudin-1 and Claudin-3 are crucial for keeping hair follicle structure and preventing a type of hair loss called telogen effluvium.

CCCA is a common, scarring hair loss in Black women that needs early detection.

Women with scarring alopecia are less likely to have used hormone replacement therapy or oral contraceptives compared to those with female pattern hair loss.

Older hair follicle stem cells have a reduced ability to renew themselves, leading to more hair loss.

The conclusion is that the cornea has two types of stem cells, with Lrig1+ cells being key for renewal in aging corneas, independent of CD44.

A new treatment using AGED to modulate PPAR-γ shows promise for treating scarring hair loss by protecting and repairing hair follicle cells.

Macrophages are more involved in Lichen planopilaris than in Frontal fibrosing alopecia.

Topical tofacitinib is effective in promoting hair growth for non-scarring alopecia.

The symposium highlighted the importance of understanding disease mechanisms for targeted dermatology treatments.

Tofacitinib helped over half of the patients with severe hair loss regrow at least 50% of their hair.

Both induced and spontaneous AA lymphocytes can cause alopecia areata in mice.

Combining microdermabrasion with steroid injections improves hair regrowth in scalp alopecia areata.

The document concludes that doctors should recognize congenital triangular alopecia to avoid unnecessary treatments, as it does not respond to steroids like alopecia areata does.